发明公开
EP2894169A1 FUSION PROTEIN COMPRISING AXL AND COMPOSITION FOR TREATING CANCER COMPRISING SAME
有权
FUSIONSPROTEIN麻醉师AXL SOWIE ZUSAMMENSETZUNG ZUR KREBSBEHANDLUNG DAMIT
- 专利标题： FUSION PROTEIN COMPRISING AXL AND COMPOSITION FOR TREATING CANCER COMPRISING SAME
- 专利标题（中）： FUSIONSPROTEIN麻醉师AXL SOWIE ZUSAMMENSETZUNG ZUR KREBSBEHANDLUNG DAMIT
-
申请号： EP13836076.3申请日： 2013-09-06
-
公开(公告)号： EP2894169A1公开(公告)日： 2015-07-15
- 发明人: SEO, Jeong-Sun , KIM, Young-Tae , JU, Young-Seok , KIM, Eun-Hee , KANG, Jin-Hyoung
- 申请人： Macrogen Inc. , SNU R&DB Foundation , Catholic University Industry-Academic Cooperation Foundation
- 申请人地址： 10th Floor Worldmerdian Venture Center 60-24 Gasan-dong Geumcheon-gu Seoul 153-781 KR
- 专利权人： Macrogen Inc.,SNU R&DB Foundation,Catholic University Industry-Academic Cooperation Foundation
- 当前专利权人： Macrogen Inc.,SNU R&DB Foundation,Catholic University Industry-Academic Cooperation Foundation
- 当前专利权人地址： 10th Floor Worldmerdian Venture Center 60-24 Gasan-dong Geumcheon-gu Seoul 153-781 KR
- 代理机构： Krauns, Christian
- 优先权： KR20120099616 20120907
- 国际公布： WO2014038890 20140313
- 主分类号： C07K19/00
- IPC分类号： C07K19/00 ; C12N15/62 ; C12Q1/68 ; A61P35/00
摘要：
Provided is a fusion protein comprising AXL receptor tyrosine kinase (AXL protein) and MAP3K12 binding inhibitory protein 1 (MBIP protein), a composition for diagnosing a cancer comprising a substance interacting with the fusion protein, a method of providing information for diagnosing a cancer using the fusion protein, a composition for preventing and/or treating a cancer comprising an inhibitor against the fusion protein, and a method for screening an anticancer agent using the fusion protein.
公开/授权文献
信息查询
